tecfidera
biogen netherlands b.v. - dimetyylifumaraatti - multippeliskleroosi - immunosuppressantit - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
tysabri
biogen netherlands b.v. - natalitsumabin - multippeliskleroosi - selektiiviset immunosuppressantit - tysabri is indicated as single disease modifying therapy in adults with highly active relapsing remitting multiple sclerosis for the following patient groups: , patients with highly active disease activity despite a full and adequate course of treatment with at least one disease modifying therapy (dmt) (for exceptions and information about washout periods see sections 4. 4 ja 5. 1), , or, patients with rapidly evolving severe relapsing remitting multiple sclerosis defined by 2 or more disabling relapses in one year, and with 1 or more gadolinium enhancing lesions on brain mri or a significant increase in t2 lesion load as compared to a previous recent mri.
isotretinoin orion 20 mg kapseli, pehmeä
pharmathen s.a. - isotretinoin - kapseli, pehmeä - 20 mg - isotretinoiini
queloran 50 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 50 mg - ketiapiini
queloran 150 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 150 mg - ketiapiini
queloran 200 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 200 mg - ketiapiini
queloran 300 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 300 mg - ketiapiini
queloran 400 mg depottabletti
pharmathen s.a. pharmathen s.a. - quetiapini fumaras - depottabletti - 400 mg - ketiapiini
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin asetaatti - diagnostisia tekniikoita, hormonitoimintaa - macimorelin - tämä lääkevalmiste on tarkoitettu vain diagnostiseen käyttöön. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.
stelfonta
qbiotics netherlands b.v. - tigilanol tiglate - tigilanol tiglate - koirat - hoitoon ei-resectable non-metastaattinen (joka lavastus) ihon alle mast-solu kasvain sijaitsee tai distaalinen kyynärpää tai hock, ja ei-resectable non metastasoitunut ihon mast-solujen kasvaimia koirilla.